Equity Details
Price & Market Data
Price: $4.89
Daily Change: +$0.314 / 6.42%
Daily Range: $4.44 - $4.99
Market Cap: $19,345,490
Daily Volume: 77,051
Performance Metrics
1 Week: 9.50%
1 Month: 14.96%
3 Months: 105.1%
6 Months: -1.26%
1 Year: -61.89%
YTD: 101.7%
About SeaStar Medical Holding Corporation (ICU)
A complete market overview for SeaStar Medical Holding Corporation (ICU). The stock is at 4.89, with a daily change of +$0.314 / 6.42%. Market cap: 19,345,490. Delve into its YTD and 3-month performance.
Company Details
Employees: 17
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.